ALX Oncology Holdings Inc. (ALXO)
NASDAQ: ALXO · Real-Time Price · USD
0.5500
+0.0171 (3.21%)
May 5, 2025, 4:00 PM EDT - Market closed
ALX Oncology Holdings Balance Sheet
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
Fiscal Year | FY 2024 | FY 2023 | FY 2022 | FY 2021 | FY 2020 | 2018 - 2019 |
|---|---|---|---|---|---|---|
Period Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | 2018 - 2019 |
| Cash & Equivalents | 17.57 | 22.41 | 48.82 | 363.67 | 434.22 | Upgrade
|
| Short-Term Investments | 110.19 | 160.33 | 217.39 | - | - | Upgrade
|
| Cash & Short-Term Investments | 127.76 | 182.74 | 266.21 | 363.67 | 434.22 | Upgrade
|
| Cash Growth | -30.09% | -31.36% | -26.80% | -16.25% | 4715.56% | Upgrade
|
| Other Receivables | 0.89 | 1 | - | - | - | Upgrade
|
| Receivables | 0.89 | 1 | - | - | - | Upgrade
|
| Prepaid Expenses | 5.68 | 4.49 | 4.76 | 3.35 | 1.77 | Upgrade
|
| Other Current Assets | 0.03 | 0.44 | - | - | - | Upgrade
|
| Total Current Assets | 134.35 | 188.66 | 270.97 | 367.02 | 435.99 | Upgrade
|
| Property, Plant & Equipment | 9.63 | 10.84 | 9.81 | 3.47 | 0.05 | Upgrade
|
| Long-Term Investments | 3.52 | 35.41 | 16.7 | - | - | Upgrade
|
| Other Long-Term Assets | 0.27 | 7.64 | 9.01 | 9.69 | 0.01 | Upgrade
|
| Total Assets | 147.78 | 242.55 | 306.49 | 380.18 | 436.05 | Upgrade
|
| Accounts Payable | 4.5 | 8.59 | 8.07 | 3.76 | 0 | Upgrade
|
| Accrued Expenses | 9.26 | 15.44 | 10.79 | 9.6 | 3.68 | Upgrade
|
| Current Portion of Long-Term Debt | 0.44 | - | - | - | - | Upgrade
|
| Current Portion of Leases | 1.91 | - | - | 0.74 | - | Upgrade
|
| Current Income Taxes Payable | - | - | - | - | 0.18 | Upgrade
|
| Other Current Liabilities | 2.39 | 11.97 | 9.46 | 1.19 | 2.35 | Upgrade
|
| Total Current Liabilities | 18.5 | 36 | 28.33 | 15.3 | 6.2 | Upgrade
|
| Long-Term Debt | 9.47 | 9.64 | 9.39 | - | - | Upgrade
|
| Long-Term Leases | 5.16 | - | - | - | - | Upgrade
|
| Other Long-Term Liabilities | 1.03 | 7.2 | 5.31 | 1.84 | 0.01 | Upgrade
|
| Total Liabilities | 34.16 | 52.84 | 43.03 | 17.13 | 6.21 | Upgrade
|
| Common Stock | 0.05 | 0.05 | 0.04 | 0.04 | 0.04 | Upgrade
|
| Additional Paid-In Capital | 734.41 | 675.68 | 589.74 | 564.99 | 548.33 | Upgrade
|
| Retained Earnings | -621.12 | -486.27 | -325.47 | -201.99 | -118.52 | Upgrade
|
| Comprehensive Income & Other | 0.28 | 0.26 | -0.85 | - | - | Upgrade
|
| Total Common Equity | 113.62 | 189.71 | 263.46 | 363.05 | 429.85 | Upgrade
|
| Shareholders' Equity | 113.62 | 189.71 | 263.46 | 363.05 | 429.85 | Upgrade
|
| Total Liabilities & Equity | 147.78 | 242.55 | 306.49 | 380.18 | 436.05 | Upgrade
|
| Total Debt | 16.98 | 9.64 | 9.39 | 0.74 | - | Upgrade
|
| Net Cash (Debt) | 110.78 | 173.1 | 256.82 | 362.93 | 434.22 | Upgrade
|
| Net Cash Growth | -36.00% | -32.60% | -29.24% | -16.42% | 11975.06% | Upgrade
|
| Net Cash Per Share | 2.12 | 4.03 | 6.31 | 9.00 | 23.49 | Upgrade
|
| Filing Date Shares Outstanding | 53.38 | 50.15 | 40.86 | 40.63 | 40.13 | Upgrade
|
| Total Common Shares Outstanding | 53.05 | 49.95 | 40.86 | 40.59 | 39.84 | Upgrade
|
| Working Capital | 115.85 | 152.66 | 242.64 | 351.72 | 429.79 | Upgrade
|
| Book Value Per Share | 2.14 | 3.80 | 6.45 | 8.94 | 10.79 | Upgrade
|
| Tangible Book Value | 113.62 | 189.71 | 263.46 | 363.05 | 429.85 | Upgrade
|
| Tangible Book Value Per Share | 2.14 | 3.80 | 6.45 | 8.94 | 10.79 | Upgrade
|
| Machinery | 2.47 | 2.31 | 1.93 | 0.73 | 0.07 | Upgrade
|
| Leasehold Improvements | 2.51 | 2.51 | 2.36 | 0.23 | 0.01 | Upgrade
|
Updated Mar 6, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.